STROUHALOVA, D., D. MACEJOVA, B. MOSNA, Pavel BOBÁĽ, Jan OTEVŘEL, M. LASTOVICKOVA, J. BRTKO a J. BOBALOVA. Down-regulation of vimentin by triorganotin isothiocyanates-nuclear retinoid X receptor agonists: A proteomic approach. Toxicology Letters. CLARE: Elsevier, 2020, roč. 318, č. 318, s. 22-29. ISSN 0378-4274. Dostupné z: https://dx.doi.org/10.1016/j.toxlet.2019.10.004.
Další formáty:   BibTeX LaTeX RIS
Základní údaje
Originální název Down-regulation of vimentin by triorganotin isothiocyanates-nuclear retinoid X receptor agonists: A proteomic approach
Autoři STROUHALOVA, D., D. MACEJOVA, B. MOSNA, Pavel BOBÁĽ (703 Slovensko, domácí), Jan OTEVŘEL (203 Česká republika, domácí), M. LASTOVICKOVA, J. BRTKO a J. BOBALOVA.
Vydání Toxicology Letters, CLARE, Elsevier, 2020, 0378-4274.
Další údaje
Originální jazyk angličtina
Typ výsledku Článek v odborném periodiku
Obor 30104 Pharmacology and pharmacy
Stát vydavatele Irsko
Utajení není předmětem státního či obchodního tajemství
WWW URL
Impakt faktor Impact factor: 4.372
Kód RIV RIV/00216224:14160/20:00118220
Organizační jednotka Farmaceutická fakulta
Doi http://dx.doi.org/10.1016/j.toxlet.2019.10.004
UT WoS 000496792900003
Klíčová slova anglicky Triorganotin isothiocyanates; Breast cancer; Proteomic; iTRAQ; Vimentin
Štítky rivok, ÚChL
Příznaky Mezinárodní význam, Recenzováno
Změnil Změnila: Mgr. Hana Hurtová, učo 244985. Změněno: 24. 2. 2021 08:46.
Anotace
An attempt has been made to delineate the role of natural and synthetic retinoid receptor ligands on vimentin expression in the human triple-negative breast cancer cells. The effects of currently synthesized triorganotin derivatives of the general formula R3SnX (R is butyl or phenyl, X is isothiocyanate), which are considered RXR ligands, were investigated in the human MDA-MB-231 breast cancer cell line. Studies were evaluated in the presence and absence of all-trans retinoic acid (ATRA), a natural RAR ligand. Vimentin represents the major protein associated with epithelial-mesenchymal transition (EMT), an essential process when the primary tumour transforms into a malignant one. mRNA and proteomic data obtained in this study, based on the PDQuest software protein evaluation and further quantification of proteins by iTRAQ analysis, suggest that vimentin was significantly reduced in the combination of RAR ligand and RXR ligand treatment. Both tested triorganotin compounds showed similarly reduced expression of vimentin, but tributyltin isothiocyanate (TBT-ITC) proved to be more effective than triphenyltin isothiocyanate (TPT-ITC). Furthermore, the effect of natural (9cRA) and synthetic RXR ligands, both chloride and isothiocyanate derivatives, on vimentin expression was compared.
VytisknoutZobrazeno: 28. 7. 2024 08:20